Interesting that while the focus is on voter integrity, no one is talking about the CORRUPT SOROS VOTING MACHINES.
But, that is just too obvious I guess.
Interesting that while the focus is on voter integrity, no one is talking about the CORRUPT SOROS VOTING MACHINES.
But, that is just too obvious I guess.
Think these connect.
What "Deal" was LJ offered?
Same shit, different bitch?
Corrupt AG's?
Odd wording.
A growing number of UTIs are resistant to antibiotics. Experts say it's the 'canary in the coal mine' for a bigger problem.
There's a new FDA-approved antibiotic for UTIs, but more are needed.
Mo Carrier has dealt with recurrent urinary tract infections, defined as having three or more UTIs per year or two infections within six months, since her early 20s. “I ended up being put on antibiotics to be used before every sexual act,” she tells Yahoo Life. Carrier eventually switched doctors and says her access to antibiotics changed. Among other things, her new doctor was concerned about antibiotic resistance, which happens when the bacteria no longer responds to certain antibiotics.
“I’d used [antibiotics] probably three times a week for about a year at that point,” she says. Carrier says she was “terrified” that the antibiotics would one day stop working for her. “UTIs were one of the worst things I’ve been through,” she adds.
Liz S. also struggles with recurrent UTIs, but has another challenge: She’s allergic to sulfa-based antibiotics, which limits the type of medication she can take. Liz tells Yahoo Life that antibiotic resistance is “definitely a concern, given that I can't take one of the three standard medications.”
In March 2025, the Food and Drug Administration approved a new medication — gepotidacin, sold under the brand name Blujepa — to treat UTIs, making it the first new antibiotic class in nearly 30 years. That’s good news for the more than 50% of women who will have at least one UTI in their lifetime, along with the 30-44% of women whose UTI will inevitably return in a matter of months. (Drugs Pivya and Orlynvah were approved in 2024 to treat UTIs, but they fit into existing antibiotic classes; Blujepa is a triazaacenaphthylene antibiotic and is the first of its kind.)
Why all the new medications? Recurrent UTIs have become a growing problem due to antibiotic resistance, meaning some of the drugs that were once used to treat them are no longer effective. Research suggests that 92% of bacteria that cause UTIs are resistant to at least one antibiotic, and nearly 80% are resistant to at least two antibiotics — and that’s raising somered flags.
But the problem with antibiotic resistance is bigger than just UTIs.The World Health Organization (WHO) has labeled antibiotic resistance as one of the three greatest threats to global health.The National Institutes of Health (NIH) says it’s a serious threat, while research calls antibiotic resistance a “global health emergency.”
Antibiotic resistance is a growing problem
“Antibiotic-resistant UTIs are the canary in the coal mine for broader antibiotic resistance,” Dr. Robert Bonomo, antibiotic resistance researcher and professor in the Department of Medicine at the Case Western Reserve University School of Medicine, tells Yahoo Life. Bonomo says that doctors will often prescribe many antibiotics over time to treat these recurrent infections, raising the risk that bacteria will adapt and eventually thwart the medication’s effects.
Moar
https://www.yahoo.com/lifestyle/a-growing-number-of-utis-are-resistant-to-antibiotics-experts-say-its-the-canary-in-the-coal-mine-for-a-bigger-problem-090010153.html
Tell me, this is Constitutional.
Government overreach in OVERDRIVE.
Tracking CITIZENS? Instead of ILLEGAL ALIENS, casue that is just RACIAL profiling?
Such a bunch of shit. This is the TSA restrict LEGAL CITIZENS because CORRUPT DEMONS plotted the greatest AMERICAN tragedy to steal our money, all over again.
Deadline looming. May 7. Prisoner of Commie Fornia.
https://www.dmv.ca.gov/portal/driver-licenses-identification-cards/real-id/what-is-real-id/
FAKE NEWS DELTA
YAY. Y HEADS WINNING!!
MOAR SUPPORT TO KIDNAP CHILDREN FOR THE US GOVERNMENT HHS, CLINTON RICO MAFIA.
Don't pretend this administration gives a shit either. That is the BIGGEST LET DOWN EVER.
Know, you will be hung out to dry.
>Trump FDA has granted fast track designation for a "self-amplifying mRNA vaccine"
"Fast tracked." Sure. Just like Moderna and DARPA and GATES, who HAD BEEN in development DECADES prior?
Spoopy name. Arcturus? Like Arcturians? They fucking ruin everything.
SAN DIEGO - Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a biotechnology firm specializing in mRNA medicines with a market capitalization of $266 million, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to its self-amplifying mRNA vaccine candidate, ARCT-2304. The vaccine is aimed at providing immunity against the H5N1 subtype of influenza A, a virus with potential pandemic implications. According to InvestingPro data, the company maintains a strong liquidity position with more cash than debt on its balance sheet.
The Fast Track Designation is intended to facilitate the development and expedite the review of drugs and vaccines that treat serious conditions and fill an unmet medical need. Benefits of this designation include more frequent meetings with the FDA, potential for priority review, and the possibility of submitting sections of a New Drug Application on a rolling basis. While the company's stock has faced challenges, declining over 69% in the past year, InvestingPro analysis suggests the stock may be undervalued at current levels.
The Phase 1 clinical study for ARCT-2304 began in November 2024, testing its safety and efficacy. With a current ratio of 4.67, the company appears well-positioned to fund its clinical development programs. Joseph Payne, President and CEO of Arcturus, expressed the company's commitment to developing mRNA vaccines to protect against pandemic threats and regarded the FDA's recognition as a significant milestone in their mission.
ARCT-2304 utilizes Arcturus's proprietary LUNAR® delivery technology and STARR® mRNA technology. The vaccine is designed to replicate mRNA within host cells to produce antigens at lower doses than traditional mRNA vaccines. This technology also aims to facilitate quicker vaccine availability compared to conventional egg- and cell-based methods. Moreover, ARCT-2304's stability in refrigerator temperatures could improve distribution logistics.
https://www.investing.com/news/company-news/arcturus-vaccine-gets-fda-fast-track-for-h5n1-influenza-93CH-3979080
>Arcturus Therapeutics Holdings
CEO:Joseph E. Payne(May 31, 2018–)
President: Joseph E. Payne
Headquarters: California
Date founded: 2013
Subsidiaries: Alcobra Inc., Arcturus Therapeutics, Inc.
Traded as: Nasdaq: ARCT
Rory>Cory
Sauce that book, please